Q2 2016 Holdings
Filed 2016-08-10 | 91 holdings | $23.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ellomay Capital Limited(ELLO) | SHS | M39927120 | $43 | 5,653 | 0.0% |
| Ishares TRPut | PUT | 464287955 | $200 | 2,000 | 0.0% |
| Insys Therapeutics Inc New | COM NEW | 45824V209 | $212 | 16,407 | 0.0% |
| Scynexis Inc | COM | 811292101 | $279 | 128,500 | 0.0% |
| Abeona Therapeutics Inc(ABEO1EUR) | COM | 00289Y107 | $326 | 138,105 | 0.0% |
| Palatin Technologies Inc | COM PAR $ .01 | 696077403 | $448 | 1,015,374 | 0.0% |
| Sapiens Intl Corp N V | SHS NEW | N7716A151 | $714 | 60,949 | 0.0% |
| Catabasis Pharmaceuticals in | COM | 14875P107 | $752 | 203,243 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $819 | 150,000 | 0.0% |
| Horizon Pharma PLC | SHS | G4617B105 | $823 | 50,000 | 0.0% |
| Oncobiologics Inc | COM | 68235M105 | $881 | 259,000 | 0.0% |
| Immunomedics Inc(IMMU) | COM | 452907108 | $928 | 400,000 | 0.0% |
| Cerulean Pharma Inc | COM | 15708Q105 | $954 | 450,000 | 0.0% |
| Servicemaster Global Hldgs I | COM | 81761R109 | $1.1K | 27,750 | 0.0% |
| Vistagen Therapeutics Inc(VTGNUSD) | COM NEW | 92840H202 | $1.1K | 294,100 | 0.0% |
| Trillium Therapeutics Inc | COM NEW | 89620X506 | $1.2K | 132,300 | 0.0% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $1.2K | 174,461 | 0.0% |
| Immune Design Corp | COM | 45252L103 | $1.2K | 153,000 | 0.0% |
| Pieris Pharmaceuticals Inc | COM | 720795103 | $1.3K | 810,000 | 0.0% |
| Valeant Pharmaceuticals Intl | COM | 91911K102 | $1.4K | 68,500 | 0.0% |
| Fibrogen Inc(FGENEUR) | COM | 31572Q808 | $1.4K | 85,700 | 0.0% |
| Egalet Corp | COM | 28226B104 | $1.5K | 292,500 | 0.0% |
| Marinus Pharmaceuticals Inc | COM | 56854Q101 | $1.5K | 1,170,643 | 0.0% |
| Edge Therapeutics Inc | COM | 279870109 | $1.5K | 150,000 | 0.0% |
| Summit Therapeutics PLC | SPONS ADS | 86627R102 | $1.6K | 197,450 | 0.0% |
| Bluebird BIO Inc | COM | 09609G100 | $1.7K | 40,000 | 0.0% |
| Inotek Pharmaceuticals Corp | COM | 45780V102 | $1.9K | 250,000 | 0.0% |
| Aduro Biotech Inc(ADROEUR) | COM | 00739L101 | $1.9K | 170,000 | 0.0% |
| Paratek Pharmaceuticals Inc | COM | 699374302 | $1.9K | 140,000 | 0.0% |
| DBV Technologies S A | SPONSORED ADR | 23306J101 | $2.0K | 60,611 | 0.0% |
| Dermira Inc(DERMEUR) | COM | 24983L104 | $2.0K | 70,000 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $2.1K | 69,500 | 0.0% |
| Clearside Biomedical Inc(CLSDUSD) | COM | 185063104 | $2.1K | 300,000 | 0.0% |
| Orbotech LTD | ORD | M75253100 | $2.2K | 84,210 | 0.0% |
| Foamix Pharmaceuticals LTD | SHS | M46135105 | $2.2K | 342,000 | 0.0% |
| Forward Pharma A/S | SPONSORED ADR | 34986J105 | $2.2K | 121,500 | 0.0% |
| Cynapsus Therapeutics Inc | COM PAR NO PAR | 23257Y859 | $2.2K | 134,037 | 0.0% |
| Endo Intl PLC | SHS | G30401106 | $2.3K | 150,000 | 0.0% |
| Relypsa Inc | COM | 759531106 | $2.4K | 130,000 | 0.0% |
| Five Prime Therapeutics Inc(FPRX) | COM | 33830X104 | $2.5K | 60,000 | 0.0% |
| Medgenics Inc | COM NEW | 58436Q203 | $2.5K | 450,000 | 0.0% |
| Acorda Therapeutics Inc | COM | 00484M106 | $2.5K | 98,000 | 0.0% |
| Kite Pharma Inc | COM | 49803L109 | $2.5K | 50,000 | 0.0% |
| Retrophin Inc | COM | 761299106 | $2.7K | 150,000 | 0.0% |
| Clovis Oncology Inc(CLVSEUR) | COM | 189464100 | $2.7K | 200,000 | 0.0% |
| Alder Biopharmaceuticals Inc | COM | 14339105 | $2.8K | 112,500 | 0.0% |
| Visa Inc(V) | COM CL A | 92826C839 | $2.8K | 37,966 | 0.0% |
| GW Pharmaceuticals PLCCall | CALL | 36197T903 | $2.8K | 310 | 0.0% |
| Genocea Biosciences Inc | COM | 372427104 | $2.9K | 709,271 | 0.0% |
| Alphabet Inc(GOOGL) | CAP STK CL A | 02079K305 | $2.9K | 4,162 | 0.0% |